Nob Hill Therapeutics Announces Strategic Advisory Board to Accelerate Growth

Nob Hill Therapeutics has recruited global thought leaders to its Strategic Advisory Board. Albuquerque, NM - Nob Hill Therapeutics (NHT) is pleased to announce the members of its Strategic Advisory Board. Under the...

Inside UCSF Innovation Ventures with Executive Director, Anthony Francis

Tell us about UCSF and what sets your institution apart? The simple answer to that question would be it’s the scientific research coupled with our focus on practical healthcare. At the University of California, San...

VIC Technology Venture Development Adds Laura Lyons to Board of Directors

Medtech veteran adds further quality, regulatory, and clinical experience FAYETTEVILLE, AR- VIC Technology Venture Development has announced the appointment of Laura Lyons, who brings 20 years of executive leadership...

Nob Hill Therapeutics to Present at Partnership Opportunities in Drug Delivery (PODD) Conference

Nob Hill Therapeutics' Executive Chairman Paul Atkins will be presenting at the Partnership Opportunities in Drug Delivery (PODD) conference during the DryNeb – Advancing Pulmonary Drug Delivery session on Friday,...

Akeso Biomedical Receives EU Authorization for CI-FER® as a Feed Additive in Piglets

CI-FER® reduces pathogen biofilms leading to improved zootechnical performance. BURLINGTON, MA – Akeso Biomedical, Inc., announced today that the company has obtained authorization in the European Union to market...

Impact Investing in Healthcare

During the past several years, the somewhat overlapping concepts of Impact Investing and Environmental, Social and Governance (ESG) are increasingly top of mind for everyday investors. Impact Investing refers to...

Future Forward: Health Innovators Launch Inventions Prompted by the Pandemic

Solaris Vaccines' Chief Scientific Officer, Raymond Goodrich, featured in CBSA article “Future Forward: Health Innovators Launch Inventions Prompted by the Pandemic." Click here to download the article.

VIC Fellows Spotlight: Secondra Holmes, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic

A promising approach for preventing cognitive and behavioral impairment following ischemic events such as cardiac arrest and stroke. Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded a...

Nob Hill Therapeutics Selected as a Finalist for RESI Innovator’s Pitch Challenge

Nob Hill Therapeutics was selected as a finalist in the Redefining Early Stage Investments (RESI) Innovator’s Pitch Challenge (IPC). An opportunity for early-stage companies to gain exposure to conference attendees,...


Zero Federal Capital Gains Taxes on High-Return Investments
White Paper
Portfolio Diversification in Times of Market Volatility
Protecting Early Investors in Capital-Intensive Life Science Companies
Inside Blackstone LaunchPad at UT Southwestern Medical Center with Brad Phelan
White Paper
University Technology Licensing: Assessing the Opportunities and Negotiating Licenses
VIC 2021 Mid-Year Update Executive Summary
Solaris Vaccines Formed to Develop and Commercialize a Rapid, Flexible Vaccine Manufacturing Platform
VIC Fellows Spotlight: Evan Goldberg, PhD
From The Corner Office
SFC Fluidics Nears FDA Submission